Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hemolytic-uremic syndrome other diagnostic studies
Introduction
Overview
Overview
Other diagnostic studies associated with HUS include complement protein levels and complement gene mutational analysis.
Other Diagnostic Studies
Other Diagnostic Studies
Other diagnostic studies associated with HUS include complement protein levels and complement gene mutational analysis.[1]
- Complement factor C3 mutation
- Complement factor C4 mutation
- Complement factor B mutation
- Complement factor H mutation
- Complement factor H-related (CFHR) genes 1-3 mutations
- Complement factor I mutation
- Membrane cofactor protein (MCP) mutation
- Thrombomodulin (THBD) mutation
- Anti-Complement factor H antibody
In most cases of STEC-associated HUS, routine screening for complement regulatory gene mutations is not warranted on the basis of current data.[2]
References
References
- ↑ Loirat C, Frémeaux-Bacchi V (2011). “Atypical hemolytic uremic syndrome”. Orphanet J Rare Dis. 6: 60. doi:10.1186/1750-1172-6-60. PMC 3198674. PMID 21902819.
- ↑ Freedman SB, van de Kar NC, Tarr PI (October 2023). “Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome”. N Engl J Med. 389 (15): 1402–1414. doi:10.1056/NEJMra2108739. PMID 37819955 Check
|pmid=value (help).
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [3] Parth Vikram Singh, MBBS[4]